Every Form 4 that NuCana plc (NCNA) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow NCNA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NCNA filings page.
NuCana plc director Elliott M. Levy reported the cancellation of an option covering 23,811,896 ordinary shares. The Form 4 shows a derivative transaction coded as a disposition to the issuer, leaving no options of this grant outstanding after the transaction.
According to the footnotes, these ordinary shares had an exercise price of 0.0004 Pounds Sterling per share, were exercisable as of June 20, 2026, and were scheduled to expire on June 20, 2035. The option was canceled by mutual agreement between Levy and NuCana, and Levy did not receive any consideration for this cancellation.
NuCana plc’s Chief Medical Officer Jeffrey D. Bloss agreed to cancel a portion of his stock options. He disposed of 36,539,720 options to the company as a disposition to issuer, without receiving any cash or other consideration.
The canceled options were part of a grant of 146,158,880 options with an exercise price of 0.0004 Pounds Sterling per share. Following the cancellation, 109,619,160 options tied to ordinary shares remain outstanding for Bloss and are scheduled to vest in three equal annual installments and expire on June 20, 2035, subject to his continued service.
NuCana plc granted Chief Operating Officer Theresa Margaret Bruce options over 132,600,130 Ordinary Shares. The options carry an exercise price of 0.0004 Pounds Sterling per share, aligning with the nominal value of the Ordinary Shares.
According to the award terms, 50% of the underlying shares vested on April 15, 2026, with the remaining half scheduled to vest in four equal annual installments, contingent on continued service. Following this grant, Bruce holds options over 132,600,130 Ordinary Shares that expire on April 15, 2036.